News | EP Lab | September 08, 2020

Flexible Electronics Mounted on Balloons May Improve Cardiac Catheter Ablation Procedures 

A new class of medical instruments equipped with a soft electronics may improve diagnostic and therapeutic interventions in minimally invasive procedures

A conformal array of flexible electrodes affixed to an inflated balloon catheter. The sensors have the ability to make measurements of temperature, force of contact and electrophysiological parameters, ability to customize diagnostic and therapeutic functions and offer real-time feedback. Photo by John Rogers, Northwestern University.

A conformal array of flexible electrodes affixed to an inflated balloon catheter. The sensors have the ability to make measurements of temperature, force of contact and electrophysiological parameters, ability to customize diagnostic and therapeutic functions and offer real-time feedback. Photo by John Rogers, Northwestern University.


September 8, 2020 — Researchers developed a new class of medical instruments equipped with an advanced soft electronics system that may dramatically improve the diagnoses and treatments of a number of cardiac diseases and help speed electrophysiology ablations

The use of flexible electronics on catheter devices is detailed in a new paper published in the journal Nature Biomedical Engineering.[1] Researchers, led by engineers at the George Washington University and Northwestern University, applied stretchable and flexible matrices of electrode sensors and actuators, along with temperature and pressure sensors, to a balloon catheter system. These balloons are used in minimally invasive, catheter-based therapies or ablations to treat heart arrhythmias.

“We have taken new breakthrough materials and fabrication techniques typically employed by the semiconductor industry and applied them to the medical field, in this case cardiology, to advance a new class of medical instruments that will improve cardiac outcomes for patients and allow physicians to deliver better, safer and more patient-specific care," said Igor Efimov, the Alisann and Terry Collins Professor of Biomedical Engineering at the George Washington University.

The new system conforms better to the body’s soft tissue than current devices and can perform a variety of functions. These include: simultaneous in vivo measurements of temperature, force of contact and electrophysiological parameters; the ability to customize diagnostic and therapeutic functions; and real-time feedback. The new system can also dramatically reduce the length of catheter-based electrophysiology (EP) ablation procedures and exposure of patients and doctors to X-ray radiation from the cath lab angiography imaging systems.

Though widely used, the current catheter-based approach has a number of drawbacks. The rigidity of today’s catheter devices means they do not conform well to soft, biological tissues, impacting high fidelity mapping of an organ’s electrophysiological signals. Current devices make contact with only a small part of an organ at a time, making it necessary to constantly move a probe around, lengthening medical procedures. Current catheter systems are also limited in the number of functions they can perform, requiring physicians to use multiple catheters in a single ablation procedure.
Additionally, long procedures — for example, to locate and ablate tissues causing arrhythmias — risk exposing both patient and physician to potentially damaging X-rays from imaging used to guide the catheters.
 
This new class of instruments the researchers developed will allow physicians to acquire a rich set of electrophysiological information and to complete surgeries in shorter times with a single instrumented catheter system.

By outfitting a balloon catheter with advanced organ conformal electronic components, sensors and actuators, the researchers overcame the limitations of current systems. Specific advances over previous systems include:
   • Instrumented sensors and actuators in multiplexed array formats can probe the complex nature of tissues, specifically in the beating heart. This will allow, for example, for better localization of sources of lethal arrhythmias causing sudden cardiac death.
   • The device’s multilayered and multifunctional architecture with combined diagnostic and therapeutic functions enhances a number of minimally invasive cardiac procedures, including radio frequency or irreversible electroporation ablation—wherein cardiac or nerve cells are ablated, or “burned,” to eliminate sources of arrhythmia—and the delivery of drugs and other biomaterials directly into cells through a process called reversible electroporation.
   • Capabilities for real-time feedback control, enabled by simultaneous, multimodal operation of sensors and actuators.


“Hard, rigid catheters cannot conform to the heart because the heart itself is not hard and rigid. We leveraged our advances in soft, stretchable and flexible electronics to develop medical devices that include elastic, interconnected arrays of sensors and actuators, capable of gently and softly conforming to tissue surfaces. The result improves the accuracy and precision of associated surgical processes, for faster, less risky and more effective treatments,” explained John A. Rogers, Ph.D., the Louis A. Simpson and Kimberly Querrey Professor of Materials Science and Engineering, Biomedical Engineering and Neurological Surgery at Northwestern University.

Reference:
1. Han, M., Chen, L., Aras, K. et al. Catheter-integrated soft multilayer electronic arrays for multiplexed sensing and actuation during cardiac surgery. Nat Biomed Eng (2020). https://doi.org/10.1038/s41551-020-00604-w.


Related Content

News

Oct. 24, 2024 — Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera ...

Home October 30, 2024
Home
News

Oct. 18, 2024 — Boston Scientific Corp. recently announced it has received U.S. Food and Drug Administration (FDA) ...

Home October 21, 2024
Home
News

May 15, 2024 —CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac ...

Home May 15, 2024
Home
News

May 13, 2024 — Innovative Health, Inc. announced that recent growth in single-use device reprocessing has delivered ...

Home May 13, 2024
Home
News

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023
Home
News

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023
Home
News

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

Home January 31, 2023
Home
News

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
News

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
News

May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

Home May 13, 2022
Home
Subscribe Now